Literature DB >> 15047952

Linkage of neutrophil serine proteases and decreased surfactant protein-A (SP-A) levels in inflammatory lung disease.

F Rubio1, J Cooley, F J Accurso, E Remold-O'Donnell.   

Abstract

BACKGROUND: In patients with cystic fibrosis (CF) neutrophils are recruited in excess to the airways yet pathogens are not cleared and the patients suffer from chronic infections. Recent studies have shown a deficiency in airway fluids from patients with CF and other inflammatory pulmonary conditions of surfactant protein A (SP-A), a pattern recognition molecule that facilitates uptake of microbes by macrophages and neutrophils.
METHODS: In vitro simulations were used to test the hypothesis that decreased SP-A levels in CF might be the result of degradation by neutrophil serine proteases.
RESULTS: Very low levels of the neutrophil granule serine proteases cathepsin G, elastase, and proteinase-3 rapidly degraded pure SP-A when tested in buffered saline. The order of potency was cathepsin G>elastase>proteinase-3. The addition of cathepsin G or elastase to normal bronchoalveolar lavage (BAL) fluid caused a dose dependent degradation of endogenous native SP-A. Cathepsin G and elastase were present in the BAL fluid from many patients with CF. Simple incubation of protease positive BAL fluid from patients with CF caused a time dependent degradation of added SP-A or, where present, endogenous SP-A. The degradation of SP-A by protease(s) in BAL fluid of patients with CF was abrogated by diisopropylfluorophosphate and monocyte/neutrophil elastase inhibitor.
CONCLUSIONS: The findings strongly suggest that the neutrophil serine proteases cathepsin G and/or elastase and/or proteinase-3 contribute to degradation of SP-A and thereby diminish innate pulmonary antimicrobial defence.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15047952      PMCID: PMC1763800          DOI: 10.1136/thx.2003.014902

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  34 in total

1.  Pulmonary surfactant in cystic fibrosis.

Authors:  M Griese; P Birrer; A Demirsoy
Journal:  Eur Respir J       Date:  1997-09       Impact factor: 16.671

2.  Cystic fibrosis lung inflammation: early, sustained, and severe.

Authors:  A Cantin
Journal:  Am J Respir Crit Care Med       Date:  1995-04       Impact factor: 21.405

3.  Introduction of mannose binding protein-type phosphatidylinositol recognition into pulmonary surfactant protein A.

Authors:  H Chiba; H Sano; M Saitoh; H Sohma; D R Voelker; T Akino; Y Kuroki
Journal:  Biochemistry       Date:  1999-06-01       Impact factor: 3.162

4.  Cystic fibrosis sputum induces a secretory response from airway gland serous cells that can be prevented by neutrophil protease inhibitors.

Authors:  A Schuster; J V Fahy; I Ueki; J A Nadel
Journal:  Eur Respir J       Date:  1995-01       Impact factor: 16.671

5.  Proteinase 3, a potent secretagogue in airways, is present in cystic fibrosis sputum.

Authors:  V Witko-Sarsat; L Halbwachs-Mecarelli; A Schuster; P Nusbaum; I Ueki; S Canteloup; G Lenoir; B Descamps-Latscha; J A Nadel
Journal:  Am J Respir Cell Mol Biol       Date:  1999-04       Impact factor: 6.914

Review 6.  Immunomodulatory functions of surfactant.

Authors:  J R Wright
Journal:  Physiol Rev       Date:  1997-10       Impact factor: 37.312

7.  Epitope mapping for monoclonal antibody against human surfactant protein A (SP-A) that alters receptor binding of SP-A and the SP-A-dependent regulation of phospholipid secretion by alveolar type II cells.

Authors:  N Hiraike; H Sohma; Y Kuroki; T Akino
Journal:  Biochim Biophys Acta       Date:  1995-08-03

8.  Deficient hydrophilic lung surfactant proteins A and D with normal surfactant phospholipid molecular species in cystic fibrosis.

Authors:  A D Postle; A Mander; K B Reid; J Y Wang; S M Wright; M Moustaki; J O Warner
Journal:  Am J Respir Cell Mol Biol       Date:  1999-01       Impact factor: 6.914

9.  Surfactant content in children with inflammatory lung disease.

Authors:  A M LeVine; A Lotze; S Stanley; C Stroud; R O'Donnell; J Whitsett; M M Pollack
Journal:  Crit Care Med       Date:  1996-06       Impact factor: 7.598

10.  Inducible binding of bioactive cathepsin G to the cell surface of neutrophils. A novel mechanism for mediating extracellular catalytic activity of cathepsin G.

Authors:  C A Owen; M A Campbell; S S Boukedes; E J Campbell
Journal:  J Immunol       Date:  1995-12-15       Impact factor: 5.422

View more
  31 in total

1.  SerpinB1 in cystic fibrosis airway fluids: quantity, molecular form and mechanism of elastase inhibition.

Authors:  J Cooley; M K Sontag; F J Accurso; E Remold-O'Donnell
Journal:  Eur Respir J       Date:  2010-09-03       Impact factor: 16.671

Review 2.  Meconium-induced inflammation and surfactant inactivation: specifics of molecular mechanisms.

Authors:  Jana Kopincova; Andrea Calkovska
Journal:  Pediatr Res       Date:  2015-12-17       Impact factor: 3.756

Review 3.  Collectins and cationic antimicrobial peptides of the respiratory epithelia.

Authors:  B Grubor; D K Meyerholz; M R Ackermann
Journal:  Vet Pathol       Date:  2006-09       Impact factor: 2.221

Review 4.  Contribution of neutrophils to acute lung injury.

Authors:  Jochen Grommes; Oliver Soehnlein
Journal:  Mol Med       Date:  2010-10-18       Impact factor: 6.354

5.  The Pseudomonas aeruginosa flagellum confers resistance to pulmonary surfactant protein-A by impacting the production of exoproteases through quorum-sensing.

Authors:  Zhizhou Kuang; Yonghua Hao; Sunghei Hwang; Shiping Zhang; Eunice Kim; Henry T Akinbi; Michael J Schurr; Randall T Irvin; Daniel J Hassett; Gee W Lau
Journal:  Mol Microbiol       Date:  2011-01-06       Impact factor: 3.501

Review 6.  Neutrophil elastase inhibitors.

Authors:  William C Groutas; Dengfeng Dou; Kevin R Alliston
Journal:  Expert Opin Ther Pat       Date:  2011-01-16       Impact factor: 6.674

7.  Attenuation of host defense function of lung phagocytes in young cystic fibrosis patients.

Authors:  Neil E Alexis; Marianne S Muhlebach; David B Peden; Terry L Noah
Journal:  J Cyst Fibros       Date:  2005-12-13       Impact factor: 5.482

8.  The concentration of surfactant protein-A in amniotic fluid decreases in spontaneous human parturition at term.

Authors:  Tinnakorn Chaiworapongsa; Joon-Seok Hong; William M Hull; Chong Jai Kim; Ricardo Gomez; Moshe Mazor; Roberto Romero; Jeffrey A Whitsett
Journal:  J Matern Fetal Neonatal Med       Date:  2008-09

9.  Antiproteases as therapeutics to target inflammation in cystic fibrosis.

Authors:  Derek J Quinn; Sinéad Weldon; Clifford C Taggart
Journal:  Open Respir Med J       Date:  2010-03-30

10.  Neutrophil azurophilic granule exocytosis is primed by TNF-α and partially regulated by NADPH oxidase.

Authors:  Renee M Potera; Melissa J Jensen; Brieanna M Hilkin; Gina K South; Jessica S Hook; Emily A Gross; Jessica G Moreland
Journal:  Innate Immun       Date:  2016-09-23       Impact factor: 2.680

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.